VA removes interoperability liability in interim final rule

The Department of Veteran Affairs (VA) has released an interim final rule to amend the regulation of the applicability of VA restrictions on disclosure of certain medical information to the Department of Defense (DoD).

The rule, published Oct. 20 in the Federal Register, removes a restriction that limited the scope of information that may be interchanged and shared between VA and DoD as “information pertaining to a person relating to a period when such person is or was subject to the Uniform Code of Military Justice.”

“This restriction is narrower than the statutory restriction, and it impedes VA’s ability to share with DoD important medical information pertaining to veterans, so that we can coordinate their care and treatment,” the interim final continued.

The rule added that the restriction also impedes VA’s ability to fully engage in presidential and congressional-supported interoperability initiatives with DoD. “We note as well that this regulatory limitation was not intended to have these negative results on VA’s ability to provide high quality healthcare to veterans and, where applicable, to support DoD in similarly caring for service members and military retires,” the rule concluded.

Comments will be accepted on the interim rule until Dec. 19.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.